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GCN2 is one of four ‘‘stress kinases’’ that block
translation by phosphorylating eIF2a. GCN2 is
thought to bind uncharged tRNAs to ‘‘sense’’ amino
acid availability. In mammals, myeloid cells express-
ing indoleamine dioxygenases locally deplete trypto-
phan, which is detected by GCN2 in T cells to cause
proliferative arrest. GCN2-deficient T cells were re-
ported to ectopically enter the cell cycle when trypto-
phan was limiting. Using GCN2-deficient strains
crossed to T cell receptor (TCR) transgenic back-
grounds, we found GCN2 is essential for induction
of stress target genes such as CHOP. However,
GCN2-deficient CD8+ T cells fail to proliferate in
limiting tryptophan, arginine, leucine, lysine, or
asparagine, the opposite of what previous studies
concluded. In vitro and in vivo proliferation experi-
ments show that GCN2-deficient CD8+ T cells have
T cell-intrinsic proliferative and trafficking defects
not observed in CD4+ T cells. Thus, GCN2 is required
for normal cytotoxic T cell function.
INTRODUCTION
GCN2 (encoded by Eif2ak4 in mouse) is one of four ‘‘stress’’-
sensing kinases that phosphorylate a single known substrate:
serine 51 on the translation factor eIF2a (Donnelly et al.,
2013). Seminal work by Hinnebusch and colleagues using
yeast showed GCN2 is activated by uncharged tRNAs when
cells are starved for essential amino acids (Dong et al.,
2000; Lageix et al., 2014). Amino acid starvation causes a
rise in uncharged tRNAs, triggering dimerization and activa-
tion of GCN2’s kinase activity, which leads to phosphorylation
of serine 51 on eIF2a to block global translation and protect
cells under nutrient duress. The other three members of
the stress kinase family are activated by heme stress (HRI),
double-stranded RNA (PKR) and ER stress (PERK) (Donnelly
et al., 2013). In addition to targeting eIF2a, all four stressCell Repor
This is an open access article under the CC BY-Nkinases activate a parallel gene and protein expression
pathway mediated by activation (via translation) of the tran-
scription factor ATF4 (Harding et al., 2000). The net effect of
stress kinase activation is thought to be cellular protection
and resource conservation.
In the immune system, GCN2 appears to play several distinct
roles. For example, GCN2 is required for effective dendritic cell
activation and antigen presentation (Ravindran et al., 2014). In
T cells, a key finding by Munn, Mellor, and their colleagues
(Munn et al., 2005) found CD8+ T cells lacking GCN2 failed to
integrate signals from tryptophan starvation and ectopically
entered the cell cycle when tryptophan was limiting. Thus,
rather than arresting growth when an essential resource was
absent, GCN2-deficient cells initiated growth (Munn et al.,
2005).
Tryptophan is an important amino acid in immune regula-
tion because two enzymes, IDO1 and IDO2 (indolamine 2,3-di-
oxygenases), degrade tryptophan into kynurenines and their
downstream metabolites (Munn and Mellor, 2013). Another
tryptophan-degrading enzyme, called TDO2, is expressed pre-
dominantly in the liver and is thought to contribute to kynurenine
production (Ball et al., 2014; Bessede et al., 2014). Both kynur-
enine production and local tryptophan starvation are immuno-
regulatory, although the precise contribution of each pathway
to other different immune responses is unresolved (Moffett
and Namboodiri, 2003; Murray, 2016). In the Munn et al.
(2005) study, CD8+ T cells lacking GCN2 were exposed to con-
ditions where tryptophan amounts were artificially (via the cul-
ture media) or naturally (via other cells expressing IDO proteins)
manipulated. In another study, concordant results were re-
ported for arginine-starved T cells (Rodriguez et al., 2007).
Thus, it is widely accepted that T cells, like yeast, use GCN2
as an information processor for environmental amino acid
amounts, causing cessation of proliferation when essential
amino acids are limiting.
Here we challenge the findings concerning the link between
amino acid starvation and GCN2 in T cells. We use antigen-
specific genetic systems to show that GCN2-deficient CD4+
and CD8+ cells have overtly similar responses to control
T cells when starved of the essential amino acids leucine,
lysine, arginine, and asparagine. We found GCN2 wasts 17, 2247–2258, November 22, 2016 ª 2016 The Author(s). 2247
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. GCN2KO T Cells Fail to Proliferate
in Limiting Tryptophan
(A) Schematic of the generation of TCR transgenic
mice and the co-culture conditions.
(B) Titration assay to determine the lowest amount
of tryptophan required to induce T cell prolifera-
tion. Note that 10% FCS contains sufficient tryp-
tophan to allow one cycle of division. Therefore,
5% FCS was chosen for the subsequent studies.
(C) CFSE proliferation analysis of CD8+ division in
limiting tryptophan.
(D) CFSE proliferation analysis of CD4+ division in
limiting tryptophan.
(C and D) Representative experiments from three
independent experiments each using individual
mice are shown.dispensable for tryptophan sensing that blocks cell-cycle en-
try when amino acids are limiting. Instead, GCN2 was required
for the optimal proliferation of CD8+ T cells after antigen stim-
ulation in vitro. Loss of GCN2 had minimal effects on CD4+
T cell proliferation and selective effects on CD8+ proliferation,
especially in competitive assays. We further show the GCN2
stress pathway is necessary for CD8+ T cells to correctly
traffic to lymphoid organs, and that GCN2 pathway activation
requires independent signals: an environmental signal from
low amino acids and a second, internal signal from entry
into the cell cycle.2248 Cell Reports 17, 2247–2258, November 22, 2016RESULTS
Antigen-Specific CD4+ or CD8+ T
Cells Lacking GCN2
We generated ovalbumin (OVA)-specific
CD4+ (OT-II transgene) or CD8+ (OT-I
transgene) T cell receptor (TCR)-specific
transgenic mice on GCN2-deficient
backgrounds (GCN2KO) using mice
available from The Jackson Labora-
tory (B6.129S6-Eif2ak4tm1.2Dron/J) (Maurin
et al., 2005; Munn et al., 2005). This
Eif2ak4 allele lacks exon 12 encoding an
essential part of the kinase domain.
Splicing of exons 11–13 would result in a
frameshift and premature stop codon
(Figure S1A) that is equivalent to a null
(Harding et al., 2000; Maurin et al.,
2005). Using qRT-PCR, we confirmed
a complete absence of GCN2 mRNA
in activated CD8+ or CD4+ T cells
(Figure S1B).
GCN2-Deficient T Cells Have Intact
Tryptophan-Sensing Mechanisms
One of the key assertions of the link be-
tween GCN2 and tryptophan sensing is
that IDO1 expression in antigen-present-
ing cells (APCs) locally depletes trypto-
phan. This causes activation of theGCN2 pathway, leading to growth arrest and activation of the
stress response (Muller et al., 2008; Munn and Mellor, 2013;
Munn et al., 2005). We used an amino acid starvation system
whereby tryptophan is titrated out of the culture media and
T cell proliferation was measured (Munn et al., 2005) (Figure 1A).
Because serum contains tryptophan bound to serum proteins,
we used tryptophan-free RPMIwith serum supplements to titrate
out the amount of tryptophan available to anti-CD3/CD28-acti-
vated T cells (Munn et al., 2005). However, we were unable to
observe T cell proliferation using serum substitutes in combina-
tion with the tryptophan-free media. We reasoned serum was
required for T cells to proliferate, and therefore performed cross-
titration experiments between serum and tryptophan amounts to
arrive at a minimal serum concentration where control CD8+ cell
growth arrests in low tryptophan (5% serum; Figure 1B). In this
assay both control and GCN2-deficient T cells failed to prolifer-
ate in low concentrations of tryptophan (Figures 1C and 1D),
whereas viability was unaffected (Figure S2). Therefore, GCN2
was dispensable for CD4+ or CD8+ T cells sensing limiting tryp-
tophan to arrest cells prior to entry into the cell cycle. These data
differ from those of Munn et al. (2005), where GCN2-deficient
T cells proliferated in low tryptophan.
GCN2 Is Dispensable for Sensing Environmental Amino
Acids Required for Cell Cycle Entry
We next tested whether GCN2 had general roles in T cell-medi-
ated environmental amino acid sensing because they require
exogenous supply of most amino acids (Murray, 2016). Using
CD4+ or CD8+ GCN2KO cells, we tested whether T cells sensed
limiting arginine, lysine, or leucine in a GCN2-dependent way.
The expectation, based on other work (Munn et al., 2005; Ro-
driguez et al., 2007), was that T cells would enter the cell cycle
following TCR and co-stimulation (via CD28) engagement. This
is because GCN2 would fail to ‘‘sense’’ low amino acid concen-
trations in the media, and thus fail to block global translation.
We used an assay where peritoneal macrophages were loaded
with peptide and used as APCs with titrations of the amino acid
concentration in the media (Figure S3A). GCN2KO CD4+ or
CD8+ T cells sensed arginine, lysine, or leucine were limiting
and failed to proliferate (Figures S3B and S3C). Similar to the
approach in Figure 1, we adapted the same culture system
with lowered FCS to measure tryptophan sensing in the macro-
phage co-cultures (Figure S3D) and observed limiting trypto-
phan sensing was intact in both CD4+ and CD8+ cells (Figures
S3E and S3F).
Lymphocytes are auxotrophs for asparagine, and this property
has led to the successful development of injectable recombinant
bacterial asparaginases (ASNase) for leukemia treatment (Rub-
nitz et al., 2009). We therefore tested whether GCN2 was
required for T cell sensing of asparagine. Using an assay where
ASNase was titrated into anti-CD3/CD28-stimulated CD8+
T cells, we observed no differences in the ability of ASNase to
block T cell growth (Figure S3G). Thus, GCN2 was dispensable
for a T cell-mediated sensing pathway that blocks cell-cycle
entry when asparagine, leucine, lysine, tryptophan, and arginine
are limiting.
GCN2 Controls CD8+ Expansion and Trafficking
Given that our experiments had yet to reveal obvious relation-
ships between GCN2 and environmental amino acid sensing,
we turned to in vivo systems of proliferative T cell expansion.
To test the role of GCN2 in in vivo expansion of CD4+ T cells,
we used a CD4+-dependent colitis model. In this model, trans-
ferred CD4+ cells depleted of effector T cells (Teff) expand in vivo
and eventually cause colitis. We sorted Teff (CD4
+, CD45RBhi,
CD25) from GCN2KO or GCN2WT mice (without TCR trans-
genes) and transferred 5 3 105 cells into Rag1/ recipients,
which lack lymphocytes (Workman et al., 2011) (Figure 2A). At
the endpoint of the experiment (8 weeks), the number andphenotype of CD4+ T cells repopulating the lymphopenic hosts
were measured. Recipient mice reconstituted with GCN2WT or
GCN2KO CD4+ T cells manifested fulminant diarrhea, colitis,
and weight loss. Most importantly, the number of CD3+ T cells
in the colon and cecumwas equivalent between genotypes (Fig-
ure 2B). Therefore, GCN2 was not required for CD4+ expansion
in vivo and was not required for the acquisition of pathogenic
properties that cause colitis in this model.
To measure CD8+ expansion, we transferred naive, purified,
CSFE-labeled CD8+ GCN2KO; OT-I (CD45.2) and GCN2WT;
OT-I (CD45.1) into Rag1/ recipients at a 1:1 ratio (Figure 2C).
After 3 or 6 days, cohorts of micewere sacrificed and the number
of T cells in different organs enumerated by flow cytometry.
GCN2-deficient T cells were enriched in the spleen, but not the
cervical or mesenteric lymph nodes (MLNs) (Figures 2C and
2D). In the spleen, higher numbers of GCN2KO T cells were
recovered, which was coincident with increased proliferation
as measured by CFSE dye dilution (Figure 2E). Therefore, a frac-
tion of GCN2KO CD8+ T cells selectively trafficked to the spleen
relative to control cells injected at the same time. To confirm and
extend these observations, we performed two types of experi-
ments. First, we repeated the Rag1/ reconstitution studies
where mice were footpad immunized with OVA emulsified in
Incomplete Freund’s Adjuvant (IFA) 24 hr later and left to expand
for 6 days and then harvested, providing a readout of Ag-specific
proliferation. The popliteal LN, spleen, and cervical LNs were
harvested and the total number of cells counted, along with
the total number of divided cells. Although the ratio of GCN2KO
to GCN2WT cells remained 1:1 in the draining LNs, we observed
enrichment of GCN2KO T cells in the spleen rather than the
popliteal LN (Figure 2F).
Next, we transferred naive, purified, CSFE-labeled CD8+
GCN2KO; OT-I (CD45.2) or GCN2WT; OT-I (CD45.1) into Thy1.1
recipients at a 1:1 ratio and infected them with influenza H3N2
strain X31-OT-I, which expresses the peptide recognized by
OT-I T cells (Jenkins et al., 2006) (Figures 3A, S3A, and S3B).
Similar to what we observed in the Rag1-deficient reconstitution
model, GCN2KO; OT-I were enriched relative to control cells in
both number and percentage, especially in the spleen, but not
in the bronchoalveolar lavage (BAL), where antigen-specific pro-
liferation occurs (Figures 3C and 3D). Taken together, GCN2KO
CD8+ cells appeared to have a preferential propensity to migrate
to the spleen relative to other secondary lymphoid organs. Next,
we measured the kinetics of CD8+ trafficking in the X31-OT-I
infection system. Thy1.1 mice were reconstituted as detailed
earlier, and the percentage and number of T cells in the spleen
and BAL were measured at 3, 6, or 12 days post-infection. At
day 3, insufficient numbers of cells were recovered from either
genotype to make accurate estimates of T cell number. How-
ever, by day 6, GCN2WT; OT-I cells were detected on spleen
and BAL, and thereafter declined in number and percentage in
the former, but not latter (Figures 3E–3H). By contrast, GCN2KO;
OT-I accumulated in the spleen at day 12. The percentage and
number of GCN2KO; OT-I was lower in the BAL relative to the
co-injected control cells (Figures 3E–3H). These data, together
with the experiments in the Rag1-deficient reconstitution model,
suggested that a side-by-side test of the proliferative expansion
of CD8+ GCN2KO; OT-I versus GCN2WT; OT-I cells at the site ofCell Reports 17, 2247–2258, November 22, 2016 2249
Figure 2. GCN2 Controls In Vivo Proliferation and Splenic Trafficking of CD8+ T Cells
(A) Schematic of the experimental design to test CD4+ T cell expansion in vivo.
(B) Anti-CD3 staining of T cells in the colon and cecumof reconstitutedmice. Data are representative of two independent experiments using two to sevenmice per
group.
(legend continued on next page)
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antigen enrichment was not possible, because most GCN2KO
T cells emigrated to the spleen.
CCR7 mediates the major, but not exclusive, pathway for
CD8+ T cell enrichment in secondary lymphoid organs (Fo¨rster
et al., 1999; Sharma et al., 2015; Unsoeld et al., 2004). Therefore,
we hypothesized that GCN2 may have a cell-intrinsic influence
on CCR7 expression. Consistent with this idea, activated
GCN2KO CD8+ had increased CCR7 mRNA (Figure 3I). We next
repeated the Rag1-deficient reconstitution model where splenic
enrichment of GCN2KO CD8+ occurs (Figure 3J) and found
increased CCR7 expression on GCN2KO CD8+ relative to the
co-injected controls (Figures 3K and 3L), which was confirmed
in the influenza infection model (Figure S4C). Taken together,
our data suggest GCN2 has limited effects on CD4+ T cell expan-
sion in vivo, but plays a key role in suppressing CCR7 expression
in CD8+ cells, which leads to increased relative accumulation in
the spleen.
T Cell-Intrinsic Requirement for GCN2
in Antigen-Induced Proliferation
In the experiments shown in Figures 1, S2, and S3, we consis-
tently observed minor defects in GCN2KO CD8+ proliferation,
generally manifested under conditions of lowered amino acid
availability. Recent data have pointed to key roles for GCN2 in
regulating antigen presentation in myeloid cells (Ravindran
et al., 2014). Thus, a defect in APC function could account for
the low proliferative activity of GCN2KO; OT-I cells under condi-
tions where GCN2KO APCswere present. An alternative possibil-
ity is that GCN2 is required for T cell proliferation in a T cell-
intrinsic way. To gain more experimental control over the relative
contributions of GCN2 to antigen presentation versus prolifera-
tion in our systems, we established a ‘‘mixed leukocyte reaction’’
(MLR) culture system where ‘‘wild-type’’ LN cells (containing
T cells and APCs) were titrated with LN cells from GCN2KO;
OT-I or GCN2WT; OT-I controls (Figure 4A), allowing us to simul-
taneously control for APC effects and T cell proliferation within
the same well. When we compared the proliferation of GCN2KO;
OT-I with GCN2WT; OT-I cells mixed with different ratios of
CD45.1 cells, a striking pattern emerged where GCN2KO; OT-I
failed to proliferate efficiently, regardless of the number of input
CD45.1 (GCN2WT) cells (Figure 4B). By comparison, GCN2WT;
OT-I cells titrated with ‘‘doped’’ CD45.1 LN cells proliferated effi-
ciently under all conditions (Figures 4B and 4C). We next per-
formed a variant of this experiment where purified CD8+ T cells
from GCN2KO; OT-I to GCN2WT; OT-I mice were mixed in
different ratios of CD45.1 LN cells. Wild-type OT-I T cells prolif-
erated to a greater degree than GCN2KO; OT-I cells (Figure 4D).
The results of these experiments suggest GCN2 is required for
CD8+ T cells to proliferate in a T cell-intrinsic way. The data
also suggest GCN2 is not absolutely required for T cell prolifera-(C–E) Proliferative and trafficking defects in GCN2-deficient CD8+ T cells transf
control and GCN2KO CD45.2 T cells were transferred into Rag1/mice, and the r
assessed in the spleen, cervical, andmesenteric LNs at days 3 and 6 after transfer
group. Data from one complete experiment is shown.
(F) Ratio of CD45.1:CD45.2 CD8+ OTI+ cells in the spleen, cervical, and draining
OVA/IFA. One of two experiments using five to six mice per group is shown.
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.tion; rather, GCN2 contributes to efficient proliferation especially
in a competitive environment where other cells are dividing, or in
conditions where amino acids are limiting.
Another possibility to account for the data shown in Figure 4
was that GCN2KO; OT-I cells could have had an increased pro-
pensity to die following activation, and the differential rate of
death between GCN2WT; OT-I and GCN2KO; OT-I cells could ac-
count for the decreased proliferation observed in the GCN2KO;
OT-I cultures. Therefore, we stained activated CD8+ cells with
a viability dye across time (Haverkamp et al., 2014) and noted
minimal differences in death between GCN2KO; OT-I and con-
trols (Figure 4E).
We repeated an antigen-specific proliferation experiment
where plasmacytoid DCs were isolated from the tumor draining
lymph node (LN) of mice bearing a flank B16 melanoma. In this
system, plasmacytoid dendritic cells (pDCs) express IDO1,
causing local tryptophan depletion and blocking T cell prolifera-
tion in a tryptophan- and IDO1-dependent way (Munn et al.,
2005). Using the B16 tumor model (we note Munn et al., 2005,
used a B16 tumor expressing GM-CSF, but did not report results
from cognate controls), the same pDC sorting scheme, culture
conditions, and T cell responder system (GCN2KO; OT-I or
GCN2WT; OT-I controls) (Figures S5A and S5B), we found that
GCN2KO; OT-I failed to proliferate when exposed to tumor drain-
ing lymph node pDCs, whereas control T cells had robust prolif-
eration (Figure S5C). These data are the opposite from what
Munn et al. (2005) reported. We also performed a similar study
with a different tumor system, the EG7 thymoma, again with
the same results: GCN2-deficient CD8+ T cells had a proliferative
defect rather than ectopically entering into the cell cycle as pre-
viously reported (data not shown).
GCN2-Mediated Stress Pathway Activation in T Cells
Requires Two Signals
To gain insight into the GCN2-dependent pathways activated in
cytotoxic T cells, we quantified GCN2- and stress-dependent
gene expression in activated GCN2KO; OT-I or GCN2WT; OT-I
cells in limiting tryptophan. CHOP expression (encoded by
Ddit3), a cardinal stress kinase-activated transcription factor,
was GCN2 dependent as expected and induced 100-fold at
themRNA level by limiting tryptophan (Figure 5A). CHOP expres-
sion is therefore a sensitive readout of both GCN2 activity and
environmental amino acid amounts. Atf3, another transcription
factor activated by the stress signaling pathway, was also
GCN2 dependent, butmaximally induced later in the proliferative
process (72 h) relative to CHOP (Figure 5B).
To test whether CHOP expression was regulated by amino
acid starvation alone, we next performed experiments where pu-
rified OT-I cells were co-cultured with APCs in the presence or
absence of antigen across time (24–72 h) and under tryptophanerred into lymphopenic hosts. A total of 5 3 106 CFSE-labeled CD8+ CD45.1
atio (C), percentage (D), and proliferation (E) of CD45.1:CD45.2 CD8+ cells were
. Reconstitution experiments were performed twice using six to sevenmice per
LNs from Rag1/ reconstituted mice 6 days after footpad immunization with
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Figure 3. GCN2 Controls Trafficking and CCR7 Expression of CD8+ T Cells
(A) Congenically marked (CD45.1 or CD45.2) GCN2-deficient and WT OVA-specific CD8 T cells were mixed at equal numbers (104 each), transferred in Thy1.1
animals, and infected with influenza X31-OT-I the next day.
(B) Six days after X31-OT-I influenza infection, OVA-specific CD8+ expansion was quantified in the indicated organs and plotted as the ratio of the two cell types in
BAL, MLN, or spleen. The dotted line indicates a ratio of 1, where equal numbers of cells from both genotypes would be recovered.
(C) Percentages of CD8+ OVA-specific T cells in the BAL.
(D) Percentages of CD8+ OVA-specific T cells in MLN.
(E and F) Percentages and ratios of CD8+ T cells were quantified at day (d) 6 and d12 in the spleen.
(G and H) Percentages and ratios of CD8+ T cells were quantified at d6 and d12 in the spleen.
(legend continued on next page)
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Figure 4. GCN2 Is Required for CD8+ T Cell-
Intrinsic Proliferation
(A) Schematic of the co-culture conditions used to
mix CD45.1 and CD45.2 cells.
(B and C) Purified CSFE-labeled LN cells from
GCN2KO or GCN2WTmice crossed to the OT-I TCR
background were mixed with CFSE-labeled LN
cells from CD45.1 mice in the ratios shown with
OT-I peptide. After 72 hr, cells were stained for
CD45.1 or CD45.2, proliferation was scored in
either population, and data from the CD45.2 frac-
tion are shown. Data are representative of three
independent experiments (C).
(D) As in (B) but using purified CD8+ T cells from
GCN2KO or GCN2WTmice crossed to the OT-I TCR
background mixed with bulk LN cells as APCs.
This experiment was performed twice with similar
results. Shown is a representative experiment
where each data point represents an individual
mouse.
(E) V405 staining for cell death quantification. Ex-
periments are representative examples of two
independently performed experiments.limitation (100%, 10%, 1%, or 0% of the tryptophan concentra-
tion of RPMI). As expected from the results shown in Figure 5A,
CHOP expression was GCN2 dependent and dependent on
limiting tryptophan. However, CHOP expression was highly
dependent on TCR activation coincident with tryptophan limita-
tion (Figures 5C and 5D). We performed similar experiments in
OVA-specific CD4+ T cells and found a similar pattern to CD8+
T cells: detection of low tryptophan required GCN2 to activate
CHOP, but only when cognate TCR stimulation was present (Fig-
ure 5E). These data suggest activation of GCN2, and subsequent
activation of stress kinase transcription, is coupled to cell activa-
tion in addition to amino acid amounts, but remains independent
of the signals that block entry into the cell cycle when amino
acids are limiting.(I) Relative CCR7 mRNA in GCN2KO and GCN2WT CD8+ after 24 hr of TCR activation. Values were normaliz
(J and K) A total of 5 3 106 CFSE-labeled CD8+ CD45.1 control and GCN2KO CD45.2 T cells were transfe
(third panel), and surface CCR7 expression on CD8+ T cells were assessed on transferred cells in the spleen,
transfer (K).
(A–H) Data are representative of three independent experiments where four to six recipient Thy1.1 mice wer
four experiments where each data point represents an individual mouse. (J and K) Data are combined fr
conditions in Figures 2C–2E. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Cell ReportGCN2 Pathway Activation in T Cells
Is Not Specific for Tryptophan or
TCR Activation
Previous work has closely linked GCN2
and tryptophan starvation induced by
IDO proteins. Because GCN2 has been
proposed to bind uncharged tRNAs (Gal-
linetti et al., 2013), one possible route to
GCN2 activation is selective recognition
of the uncharged tryptophan tRNA. To
test specificity of GCN2 activation, we
incubated GCN2WT or GCN2KO cells on
an OT-I background to antigen-specificstimulation in the presence of limiting tryptophan, arginine,
leucine, or lysine (Figure 6A). In each case, CHOP expression
was induced in aGCN2-dependent way, and only when exposed
to each limiting amino acid. Therefore, GCN2 activation by
limiting amino acids is not specific for the tryptophan pathway
in T cells, consistent with data from other cellular systems
demonstrating GCN2 is a pan-amino acid sensor (Gallinetti
et al., 2013).
As shown in Figure 5, GCN2-dependent CHOP expression re-
quires activation through the TCR. These data raised the possi-
bility that GCN2 activation was specific for TCR-mediated sig-
nals, or could be a consequence of proliferation, and unrelated
to specific events downstream of the TCR (or co-stimulation
pathways). To differentiate between these possibilities, weed to GAPDH mRNA.
rred into Rag1/ mice and the ratios, percentage
cervical, and mesenteric LNs at d3 (J) and d6 post-
e used per time point. (I) Data are pooled data from
om two experiments replicating the reconstitution
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Figure 5. GCN2 Controls Stress-Response
Gene Expression to Amino Acid Starvation
and TCR Stimulation
(A) CHOP (Ddit3) and (B) Atf3mRNA in CD8+ T cells
across time of culture (24, 48, and 72 hr shown
under the abscissa) in limiting tryptophan. Color
code indicates the sampling times (24, 48, or
72 hr). Data are combined from three to four in-
dependent experiments (mean ± SEM).
(C and D) Expression of CHOP (Ddit3) in CD8+
T cells without (C) or with (D) T cell activation pro-
vided by APCs. Data are combined from two to
three individual experiments (mean ± SEM).
(E) As in (C) and (D), but with CD4+ T cells. Shown
are the averaged data from three independently
performed experiments.‘‘bypassed’’ the TCR by stimulating with PMA and ionomycin,
which supplies a strong TCR-independent proliferative signal
to T cells. We observed CHOP expression was activated only
in limiting tryptophan as before and required a general prolifera-
tive signal, because either the TCR or PMA/ionomycin was able
to induce CHOP expression in 1% tryptophan (Figure 6B).
Finally, we tested the effect of GCN2 on eIF2a Ser51 phos-
phorylation. Recent studies in fibroblasts lacking all four
stress kinases (GCN2, PERK, HRI, and PKR) have confirmed
that no other kinases phosphorylate eIF2a (Taniuchi et al.,
2016). However, the phosphorylation of eIF2a is countered by
the Ppp1r15a/Gadd34 phosphatase, which terminates stress ki-
nase signaling (Tsaytler et al., 2011). We therefore isolated CD8+
T cells from GCN2WT or GCN2KO cells on an OT-I background
andmeasured p-Ser51 on eIF2a across time of stimulation using
validated and highly specific mAbs (Taniuchi et al., 2016). We
found p-Ser51 eIF2a in all samples at time zero, which may
reflect stress from processing and purifying the T cells. Over
time, however, we found p-Ser51 eIF2a was largely dependent
on GCN2, but independent of low amino acid amounts.2254 Cell Reports 17, 2247–2258, November 22, 2016Collectively, the data in Figures 5 and 6
demonstrate that stress kinase activation
through the GCN2 pathway requires two
signals in T cells; one is mediated by
limiting amino acids and is not specific
for any one amino acid, and a second
signal is linked to proliferation.
DISCUSSION
WeestablishedGCN2 has specific effects
in regulating T cell proliferation and traf-
ficking. Three significant findings from
our study were that proliferating CD8+
T cells have an obligate, but not absolute,
requirement for GCN2 that was not
observed in CD4+ T cells. A second
finding concerned the independent na-
ture of amino acid-sensing mechanisms
in T cells. A general GCN2-independent
pathway detects when environmentalamino acids are limiting and blocks cell-cycle entry after activa-
tion. However, this pathway is unconnected, or operates in par-
allel to the GCN2 pathway, which activates the canonical stress
kinase response including CHOP and Atf3 expression in low
amino acids. A third and unanticipated finding was that the tran-
scriptional program activated by GCN2 in low amino acids was
dependent on entry into the cell cycle, suggesting the GCN2
stress kinase response is required for coordinating events linked
to proliferative cycles in T cells.
We noted from in vitro experiments that GCN2-deficient CD8+
T cells did not always proliferate in an identical way to controls on
the same TCR background. Recent studies showed GCN2 has
an important role in TLR-mediated dendritic cell activation and
antigen presentation, suggesting part of the defect observed in
GCN2KO CD8+ cells could have been a property of a requirement
for GCN2 in the APCs in the culture (Ravindran et al., 2014). To
distinguish between T cell-intrinsic versus APC-intrinsic effects
of GCN2, we used experiments where CD45.1 splenocytes
were mixed in defined ratios with GCN2KO; OT-I or GCN2WT;
OT-I controls. The results showed GCN2 is intrinsically required
Figure 6. CHOP Expression Requires Prolif-
eration and GCN2
(A) Purified CD8+ cells from GCN2KO or GCN2WT
mice crossed to the OT-I TCR background were
incubated in control (normal RPMI with 10%
serum, or 5% serum when limiting tryptophan was
used) or in RPMI containing 1% tryptophan, argi-
nine, leucine, or lysine were 1% in the presence of
cognate OVA peptide. CHOP expression was
measured after 24 hr. Data are the combined re-
sults of three independent experiments.
(B) As in (A) using limiting tryptophan, but acti-
vating T cells with PMA/ionomycin for 24 hr.
Data are pooled from two to three independent
experiments.
(C) Activation of p-Ser51 on eIF2a in CD8+ T cells
activated in RPMI containing 100% or 1% trypto-
phan. Data are representative of two independent
experiments.for CD8+ proliferation under conditions of direct competition in a
closed system. Our data are consistent with another studywhere
retroviral-mediated transfer of dominant-negative GCN2 killed
T cells undergoing antigen stimulation (Scheu et al., 2006). In
that study, activation of the stress kinase response was closely
tied to TCR stimulation. When considered together, our data
and that of Scheu et al. (2006) argue for a model where GCN2,
and possibly other stress kinases, are activated bymultiple path-
ways including the stress of proliferation.
In vivo, the effects of the absence of GCN2 in CD8+ cells were
more complex. Using different transfer models into immune-defi-
cient and immune-intact backgrounds, we found GCN2 is
required to regulate the trafficking of CD8+ T cells. In the absence
of GCN2, CD8+ T cells predominantly home to the spleen, which
we discovered was linked to increased CCR7 expression in
GCN2-deficient cells. Homing of GCN2KO cells to the spleen
was a universal finding in all transfer models we tested and in
part obscured our initial investigation into Ag-specific prolifera-
tion in lungs or draining lymph nodes. In the lung, GCN2KO CD8+Cell ReportT cells had lowered proliferative capacity
compared with co-injected controls. How-
ever, thesedatamustbe interpreted in light
of the fact that most GCN2KO cells migrate
to the spleen and are not in numerically
equal competition with wild-type cells in
the same organ. Further work will be
necessary to tease apart the molecular
pathways that emanate from GCN2 to
cause the specific defects we observed.
Clearly, GCN2 is required for more than
amino acid sensing.
We found GCN2 has a greater cell-
intrinsic role in CD8+ T cells compared
with CD4+ cells. Consistent with our
data, another group showed CD4+
GCN2 had no apparent in vivo role in
amino acid sensing (Cobbold et al.,
2009). However, Scheu et al. (2006) alsoused CD4+ T cells to demonstrate the vital role of GCN2 in allow-
ing T cell proliferation. One explanation for these data concerns
the way the experiments were performed. In the genetic systems
we used, CD4+ T cells may compensate for the loss of GCN2 as
they develop and populate lymphoid tissue. By contrast, Scheu
et al. (2006) used wild-type CD4+ T cells and introduced a domi-
nant-negative GCN2; under these conditions CD4+ T cells may
not be able to adjust their stress responses quickly enough
and die. Therefore, we propose GCN2 is a component of an
overlapping and partially redundant network of kinases that
work in a lymphocyte-specific way.
Contradictory data have been published on the GCN2:IDO
connection. The Munn and Mellor model proposed that the
absence of GCN2 should cause T cells to ectopically enter into
the cell cycle in low tryptophan, which through IDO protein
expression in neighboring cells leads to a central immunoregula-
tory checkpoint (Munn and Mellor, 2013; Munn et al., 2005). Yet
the GCN2KO mice, or GCN2 mice with a complete deficiency
(Costa-Mattioli et al., 2005), have not been reported to manifests 17, 2247–2258, November 22, 2016 2255
autoimmune diseases. Further, in our hands, mice lacking IDO1
and IDO2 are immunologically normal after 1.5 years in con-
ventional housing (Van de Velde et al., 2016). Furthermore,
IDO1 was shown to have an irreplaceable role in protecting the
‘‘host’’ from the extreme inflammation associated with T cell-
mediated graft-versus-host disease. However, the effect of
IDO1 in this setting was independent of GCN2 expression in
T cells (Jasperson et al., 2009). Other data have argued GCN2
is required for arginine sensing (Highfill et al., 2010; Rodriguez
et al., 2007); like our experiments with tryptophan, we were un-
able to confirm a link between GCN2 and arginine sensing that
permits cell-cycle entry. Instead, we suggest GCN2 functions
to regulate the stress of T cell proliferative expansion specifically
in cytotoxic T cells rather than functioning as a ‘‘sensor’’ of envi-
ronmental amino acids necessary for coupling to cell-cycle en-
try. In this model GCN2 may determine amounts of uncharged
tRNA inside the cell, although there is no direct evidence to
suggest this is true: GCN2 may have different mechanisms to
control cell division. From our experiments, we can exclude
the possibility that GCN2 is exclusively required for sensing un-
charged tryptophan tRNAs, because CHOP expression was
GCN2 dependent under arginine, leucine, or lysine starvation.
Recent studies using fibroblasts lacking all four stress kinases
were used to confirm that this kinase family is solely responsible
for phosphorylation of Ser51 on eIF2a, the key event in activation
of stress kinase signaling. Using these cells reconstituted with
each individual stress kinase, Taniuchi et al. (2016) established
that multiple signals activate GCN2, including salt, arsenic, and
hydrogen peroxide. These signals may eventually impinge on
the ability of cells to make enough charged tRNAs and thus acti-
vate GCN2. Nevertheless, the activation of GCN2 appears more
complex than previously assumed. Indeed, in our experiments,
some eIF2a p-Ser51 was GCN2 dependent, but was indepen-
dent of tryptophan amounts in the cultures. To precisely connect
the molecular events linking low amino acids, GCN2 activation,
eIF2a phosphorylation, and eventual activation of stress tran-
scription, a systematic comparison of mutants in each step of
the pathway in antigen-specific T cells, including T cells bearing
eIF2a Ser51 > Ala51, will be necessary.
We note that the initial proposal that GCN2 controls the ability
of mice to sense (and avoid) meals depleted of essential amino
acids has recently been revisited (Leib and Knight, 2015; Maurin
et al., 2005). Newer findings suggest mice cannot immediately
discriminate between food lacking or replete with essential
amino acids. After a few days of exposure of amino acid-defi-
cient food, mice adapt their behavior to seek out normal food.
However, this behavior modification is independent of GCN2
(Leib and Knight, 2015), in contrast with the initial reports that
GCN2 controls feeding behavior (Maurin et al., 2005).
GCN2 has been connected to mTOR activation in some
studies. For example, GCN2 was essential for leucine-mediated
activation of mTORC1 in embryonic fibroblasts (Averous et al.,
2016). However, in our experiments in primary T cells, mTORC1
activity is coupled to activation of the T cell receptor and inde-
pendent of amino acid amounts in the media (L.V.d.V. and
P.J.M., unpublished data), suggesting amino acid sensing and
response pathways, including GCN2 and mTORC1, may have
cell-type specificity in their activation and connection to the2256 Cell Reports 17, 2247–2258, November 22, 2016necessary downstream metabolic pathways (Lee et al., 2016;
Murray, 2016). Therefore, biochemical approaches will be
necessary to establish the cell-intrinsic effects of GCN2, how
GCN2 cooperates with the other stress kinase members and
the mTOR pathway, and how the precise connection between
amino acid amounts and GCN2 activity are mediated.
EXPERIMENTAL PROCEDURES
Mice
GCN2KO (B6.129S6-Eif2ak4tm1.2Dron/J), OT-I [C57BL/6-Tg(TcraTcrb)1100Mjb/
J], OT-II [B6.Cg-Tg(TcraTcrb)425Cbn/J], CD45.1 (B6.SJL-PtprcaPepcb/BoyJ),
and Rag1/ (B6.129S7-Rag1tm1Mom/J) mice were from The Jackson Labora-
tory. GCN2KO mice were crossed with OT-I, OT-II, or DO11.10 mice and gen-
otyped using primers described on The Jackson Laboratory website (https://
www.jax.org/jax-mice-and-services). Results from the GCN2KO genotyping
PCRs were as described on The Jackson Laboratory website. The junction
point of the GCN2KO mutation was confirmed by cloning the recombination
point generated by Ron and colleagues using PCR primers and sequencing
of cloned fragments from cDNAs made from fresh bone marrow (Maurin
et al., 2005). All animals were maintained and used according to the
policies and procedures of the St. Jude Children’s Research Hospital Institu-
tional Animal Care and Use Committee under approved protocols to P.J.M. or
P.G.T.
Antibodies and Reagents
The following anti-mouse antibodies were used for flow cytometric analysis:
anti-CD4 (clone RM4-5; BioLegend), anti-CD8a (clone 53-6.7; BioLegend),
anti-CD45.1 (clone A20; BioLegend), anti-CD45.2 (clone 104; BioLegend),
anti-CD25 (clone PC61; BioLegend), anti-CD45RB (clone 16A; BD Biosci-
ences), anti-B220 (clone Ra3-6B2; BD Biosciences), anti-CD11c (clone L3;
BD Biosciences), anti-Thy1.1 (clone OX-7; BioLegend), anti-Thy1.2 (clone
53-2.1; BioLegend), and anti-CCR7 (clone 4B12; BioLegend). Antibodies for
total eIF2a and p-Ser51 eIF2a were from Cell Signaling (clones D7D3 and
D9G8 rabbit XP mAbs). OVA 257–264 and OVA 323–339 peptides were pur-
chased from American Peptide Company. Live/Dead Fixable Violet was pur-
chased from Invitrogen.
Specialized Media Formulations and Modifications
For non-titration-related experiments, RPMI 1640 (Corning) was supplemented
with 10% fetal bovine serum (FBS) (Thermo Fisher Scientific) and penicillin-
streptomycin (Gibco). Tryptophan-free RPMI 1640 was custom-made by Corn-
ing, by modifying item #10040 to exclude L-tryptophan. Tryptophan-free RPMI
1640 was supplemented with either 1 mg/mL BSA (HyClone), 10 mg/mL bovine
insulin (Sigma-Aldrich), 5 mg/mL iron-saturated transferrin (Sigma-Aldrich) and
penicillin-streptomycin, or 5%dialyzed FBS (Gibco) andpenicillin-streptomycin.
For L-arginine, L-leucine, and L-lysine titration experiments, SILAC RPMI 1640
(Sigma) was supplemented with 10%dialyzed FBS and penicillin-streptomycin.
Cell culture grade amino acids were purchased from Sigma.
T Cell Isolation and Purification
Lymph nodes (LNs) were isolated from all regions of the body except the
mesenteric LN. Single-cell suspensions were obtained by grinding the LN
through a 70 mm nylon mesh. Purified CD4+ or CD8+ populations were ob-
tained by negative selection. In brief, LN cells were incubated with biotinylated
anti-CD45R (B220, clone RA3-6B2), anti-I-A/I-E (clone M5/114.15-2), anti-
CD11b (clone M1/70), anti-CD49b (clone DX5), and either anti-CD4 (clone
GK1.5) or anti-CD8a (clone 53-607) (BioLegend). Cells were washed and incu-
bated with streptavidin microbeads (Miltenyi), washed and passed over a
magnetic column (Miltenyi), and the negative fraction collected. Cells were
then labeled with 2 mM CFDA-SE (Invitrogen) and resuspended in the appro-
priate media for the given assay.
Proliferation Assays
For Arg, Leu, or Lys titrations, thioglycollate-elicited peritoneal macrophages
from C57BL/6 mice were plated out at a density of 1 3 105 cells/well (OT-I
system) or 8.5 3 105 cells/well (OT-II system) in 24-well plates. Cells were
allowed to adhere for 2 hr and themediawere changed to remove non-adherent
cells. The following day, the media were changed and complete SILAC RPMI
containing the appropriate amino acid amounts, 0.1 mM OVA peptide, and
1 3 106 T cells were added per well. Proliferation was assessed at 72 hr by
flow cytometry.
Mixed Leukocyte Reactions
Antigen-presenting cells (APCs) were obtained by depleting CD3+ cells from
C57BL/6 splenocytes using a CD3 microbead kit (Miltenyi) according to the
manufacturer’s instructions. In 96-well flat-bottom plates, either 5 3 104
APCs (OT-I system) or 2 3 105 APCs (OT-II system) were mixed with 5 3
105 T cells in media containing a final concentration of 0.1 mM OVA peptide
and the appropriate concentration of L-tryptophan. Proliferation was assessed
at 72 hr by flow cytometry.
pDC Assay
The pDC assay was performed as described earlier, with the exception being
B16 cells were used in place of B16-GM-CSF cells (Munn et al., 2005). A total
of 1.5 3 106 B16-OVA melanoma cells or 3 3 106 EG7 thymoma cells were
implanted subcutaneously in the flank region of C57BL/6 mice. After
14 days, tumor draining LNs were harvested, and single-cell suspensions
were treated with Fc block for 10 min prior to surface staining with anti-
CD45R and anti-CD11c, and the pDC population (CD45R+ CD11c+) was
sorted. In 96-well round-bottom plates, 2.5 3 103 pDCs were mixed with
1 3 105 OT-I+ T cells in complete RPMI 1640 containing 0.1 mM OVA peptide.
L-tryptophan was added in excess as indicated in the figure legends. Prolifer-
ation was assessed at 72 hr by flow cytometry.
Asparaginase Formulations and Assays
Asparaginase (10,000 U/vial; Lundbeck) was diluted in 1 mL of PBS and
stored at 80C. Lymph node cells from OT-I or OT-II transgenic mice
were labeled with 2 mM CFSE, washed, and distributed in a 96-well plate at
1 3 106 cells/well. Cells were stimulated with plate-bound anti-CD3 and
anti-CD28 antibodies from eBioscience at final concentrations of 1.0 and
3.0 mg/mL, respectively. Asparaginase was immediately added at 0, 0.1, or
1.0 U/well (200 mL final volume). Proliferation of CD8+ or CD4+ T cells was
evaluated by flow cytometry after 72 hr.
RNA Isolation and Analysis
CD4+ or CD8+ T cells were purified from MLR using negative selection or by
cell sorting. Cells were lysed in TRIzol (Invitrogen) for subsequent RNA isola-
tion according to the manufacturer’s protocol. cDNA was synthesized using
SuperScript II reverse transcriptase, random and oligo dT primers (Invitrogen).
Eif2ak4, Ddit3, Atf4, and Ccr7 primer sets were purchased fromQiagen. SYBR
Green incorporation (Applied Biosystems) was measured using an ABI Prisms
7300 thermocycler (Applied Biosystems). All values were normalized to
GAPDH mRNA.
Teff Colitis Assays
Teff (CD4
+, CD45RBhi, CD25) from GCN2KD or GCN2WT mice were sorted on
an iCyt high-speed sorter and transferred intoRag1/ recipient mice (53 105,
intraperitoneally). Mice were monitored for signs of colitis (diarrhea, general
body condition) over an 8- to 10-week period and weighed three times per
week. Any animal losing 20% of the starting weight was removed from the
study and considered an endpoint. Mice were further analyzed by anti-CD3
immunohistochemistry of the intestines.
Rag1-Deficient Mice Reconstitution and Immunization
Rag1/ mice were retro-orbitally injected with 5 3 106 CD8+ OTI cells from
both GCN2KO CD45.2+ and GCN2WT CD45.1 mice. For homeostatic expan-
sion experiments, spleens, cervical LNs, and mesenteric LNs were harvested
6 days post-transfer, and CD8+ populations were assessed. For immunization
experiments, 25 mL of a 1:1 emulsion of incomplete Freund’s adjuvant (Thermo
Fisher Scientific) and 1 mg/ml ovalbumin protein (Sigma-Aldrich) in PBS were
injected into the footpad 24 hr post-cell transfer. At 6 days post-immunization,the draining popliteal LN, cervical LNs, and mesenteric LNs were harvested,
and CD8+ populations were assessed.
OT-I Transfer Assays and Influenza Infections
A total of 104 CD8+ CD45.1+ OT-I wild-type or CD45.2+ GCN2-deficient T cells
purified as described earlier and labeled with CFSE were injected retro-orbi-
tally into recipient Thy1.1 congenic animals. One day later, the mice were in-
fected with 105 EID50 of X31 OT-I influenza virus intranasally. On days 3, 6,
and 12 after infection, animals were euthanized and the draining mediastinal
lymph node, bronchoalveolar lavage, and spleen were sampled and analyzed
for the proliferation and phenotype of the transferred OT-I cells.
Statistics
All numerical data were processed in GraphPad Prism. Statistical compari-
sons were made using t testing, where 0.05 was considered significant and
a normal distribution was assumed. The p values are reported as follows:
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2016.10.079.
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